B1-robust and t1-robust species suppression in mri
AssigneesKabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation
InventorsAndrew J. WHEATON, James B. MURDOCH
Life of this patent
Estimating the term…
Loading patent…
AssigneesKabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation
InventorsAndrew J. WHEATON, James B. MURDOCH
Estimating the term…
An MRI multi-echo data acquisition sequence (REFUSAL=REFocusing Used to Selectively Attenuate Lipids) includes a spectrally-selective re-focusing RF pulse. The REFUSAL pulse can be non-spatially selective or spatially-selective. The REFUSAL pulse selectively refocuses water spins and avoids refocusing lipid spins. The REFUSAL pulse ideally maximizes refocusing for water and minimizes any lipid refocusing, with built-in robustness to B0-inhomogeneity and B1-inhomogeneity. Following the REFUSAL pulse, the remainder of the echo train continues in a conventional fashion. Only those spins that were refocused with the spectrally selective REFUSAL pulse continue to evolve coherently and generate a train of echoes. Those spins that were minimally refocused are spoiled and thus do not contribute signal to the final image. To incorporate a longer duration REFUSAL pulse, the echo spacing can be made non-uniform such that the first echo spacing is longer than the remainder of the echo spacings in the echo train.
An MRI method comprising using an MRI system that has been configured to:
An MRI apparatus comprising:
Apparatus for designing an MRI echo train that is spectrally-selective, B1-robust and T1-robust, said apparatus comprising a programmed computer system configured to:
Dependencies are inferred from the claim text.